Phoenixin-14 concentrations are increased in association with luteinizing hormone and nesfatin-1 concentrations in women with polycystic ovary syndrome
- 1 August 2017
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 471, 243-247
Abstract
No abstract availableKeywords
Funding Information
- NSFC-CIHR Joint Health Research Programs (81361128007)
- Canadian Institutes for Health Research China-Canada Joint Health Research Initiative (CCI-132570)
- National Natural Science Foundation of China (31671569, 81490742, 31471405)
- NSFC-CIHR Joint Health Research Program (8161101434)
This publication has 20 references indexed in Scilit:
- Phoenixin Activates Immortalized GnRH and Kisspeptin Neurons Through the Novel Receptor GPR173Molecular Endocrinology, 2016
- Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary SyndromeEndocrine Reviews, 2015
- Phoenixin: A novel peptide in rodent sensory gangliaNeuroscience, 2013
- A Novel Reproductive Peptide, PhoenixinJournal of Neuroendocrinology, 2012
- Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin‐releasing hormone secretionBJOG: An International Journal of Obstetrics & Gynaecology, 2009
- Obesity and polycystic ovary syndromeClinical Endocrinology, 2006
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Formation and early development of follicles in the polycystic ovaryThe Lancet, 2003
- Polycystic Ovary SyndromeNew England Journal of Medicine, 1995
- Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populationsFertility and Sterility, 1992